PB1863: BRUIN CLL-322: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF FIXED DURATION PIRTOBRUTINIB+VENETOCLAX AND RITUXIMAB VS VENETOCLAX AND RITUXIMAB IN PREVIOUSLY TREATED CLL/SLL (TRIAL IN PROGRESS)

Bibliographic Details
Main Authors:	A. R. Mato, W. G. Wierda, J. M. Pagel, M. S. Davids, P. L. Zinzani, Y. Lu, H. Liu, S. Shahda, C. C. Leow, C. S. Tam, J. A. Woyach, T. A. Eyre
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000850304.03677.28

Internet